Search
Pharming Group NV
PHARAdd to Watchlist
10.440USD
-0.330-3.06%
Close 09-24 16:00（ET）
738.92MMarket Cap
0.00P/E TTM
About Pharming Group NV Company
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Pharming Group NV Profile
Ticker SymbolPHAR
Company namePharming Group NV
IPO dateJul 02, 1998
CEOChouraqui (Fabrice)
Number of employees- -
Security typeDepository Receipt
Fiscal year-end- -
AddressDarwinweg 24
CityLEIDEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryNetherlands
Postal code2333 CR
Phone31715247400
Websitehttps://www.pharming.com/
Ticker SymbolPHAR
IPO dateJul 02, 1998
CEOChouraqui (Fabrice)
Company Executives of Pharming Group NV
Name
Name/Position
Position
Shareholding
Change
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni, J.D.
Ms. Barbara Yanni, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine van Der Meijs, Pharm.D.
Ms. Jabine van Der Meijs, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Alexander Breidenbach, Ph.D.
Dr. Alexander Breidenbach, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Mr. Fabrice Chouraqui, Pharm.D.
Mr. Fabrice Chouraqui, Pharm.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni, J.D.
Ms. Barbara Yanni, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine van Der Meijs, Pharm.D.
Ms. Jabine van Der Meijs, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
FAQs
Who are the top five shareholders of Pharming Group NV?
The top five shareholders of Pharming Group NV are: Mrs. Mireille Sanders
How many institutions hold shares of Pharming Group NV (PHAR)?
As of 2026Q1, 22 institutions hold shares of Pharming Group NV, with a combined market value of approximately 135.73K, accounting for 0.19% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 61813.00.